Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

NZ sharemarket edges higher as F&P Healthcare weighs on gains
Markets Market Close

NZ sharemarket edges higher as F&P Healthcare weighs on gains

The S&P/NZX 50 Index closed 14.49 points or 0.11% down at 13,391.59.

Jamie Gray 24 Oct 2025
Contact Energy expands global investor base
Markets

Contact Energy expands global investor base

Contact Energy priced an inaugural €500 million (NZ$1.01b) 7-year senior bond under its Euro Medium Term Note (EMTN) Programme, it said Friday.“This marks a milestone in Contact’s funding strategy, expanding our global investor base and reinforcing our commitment to sustainable f...

Rebecca Howard 24 Oct 2025
Kiwibank wary of capital-review barrier to growth
Finance

Kiwibank wary of capital-review barrier to growth

Kiwibank raises issues of competitive advantage.

Andy Macdonald 24 Oct 2025
Cash or invest? What Allied Farmers could do with $7m
Markets Small Cap Wrap

Cash or invest? What Allied Farmers could do with $7m

Plus, Promisia's insightful guidance, numerous AGMs, and more.